This site contains promotional information intended only for healthcare professionals resident in the United Kingdom
Sign in
Sign In or Register
Sign out

Information relating to specific disease areas aligned to Pfizer’s portfolio and other resources designed for Pfizer medicines.

See all Therapy areas

Explore Content

Information on how to access prescribing information and adverse event reporting can be found at the bottom of the page.

​​​​​​​Educational Videos

Listen to a selection of videos, where experts share their knowledge of fungal diagnostics and the challenges associated with treating invasive fungal infections.

Philip Lewis White - FRCPath, FECMM, Public Health Wales

Lateral Flow Tests for Invasive Aspergillosis

Card CTA

** This is an optional area where footnotes can live.

Philip Lewis White - FRCPath, FECMM, Public Health Wales

Lateral Flow Tests: a role in the diagnosis of COVID-19 Associated Pulmonary Aspergillosis (CAPA)

Card CTA

** This is an optional area where footnotes can live.

Andy Peniket - Consultant Haematologist, Oxford University Hospitals

Optimising Invasive Aspergillosis Treatment in the Current Environment

Card CTA

** This is an optional area where footnotes can live.

Nabeela Mughal - Consultant Microbiologist, Chelsea & Westminster NHS Foundation Trust

Treatment Pathways and Management of Haemato-oncology Patients with Invasive Fungal Infections

Card CTA

** This is an optional area where footnotes can live.

Silke Schelenz - MD, PhD, FRCPath, DipHIC, Clinical lead and laboratory director of infection sciences King’s College Hospital London

Invasive Aspergillosis Management in ICU Patients with respiratory infections

Card CTA

** This is an optional area where footnotes can live.

Phillip Lewis White - FRCPath, FECMM, Public Health Wales

Diagnostic Landscape of Invasive Mould Disease

Card CTA

** This is an optional area where footnotes can live.

Riina Richardson - DDS, PhD, FRCPath, PGCertMedEd, FECMM, Consultant in Medical Mycology

Invasive fungal infections – diagnosis, management and challenges

Card CTA

** This is an optional area where footnotes can live.

Silke Schelenz - MD, PhD, FRCPath, DipHIC, Clinical lead and laboratory director of infection sciences King’s College Hospital London

Evolving challenges in the management of difficult-to-treat fungal infections

Card CTA

** This is an optional area where footnotes can live.

Varun Mehra - Consultant Haematologist, Kings College

Case study led discussion of patient epidemiology, diagnostic pathway and treatment options for invasive mould infections

Card CTA

** This is an optional area where footnotes can live.

Patient Stories

The card body Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam.

Learn more

** This is an optional area where footnotes can live.

PP-CRB-GBR-1401. January 2022


​​Prescribing Information

Cresemba (isavuconazole)
Great Britain

Cresemba (isavuconazole) 100mg hard capsules
Cresemba (isavuconazole) 200mg powder for concentrate for solution for infusion 

Northern Ireland
Cresemba (Isavuconazole) 100mg hard capsules and Cresemba (Isavuconazole) 200mg powder for concentrate for solution for infusion

Vfend (voriconazole)
​​​​​​​
Great Britain
​​​​​​​Vfend (voriconazole) 50mg film coated tablets
Vfend (voriconazole) 200mg film coated tablets
Vfend (voriconazole) 200mg powder for solution for infusion
Vfend (voriconazole) 40mg/ml powder for oral suspension

Northern Ireland
​​​​​​​
Vfend (voriconazole): 50mg film coated tablets, 200mg film coated tablets & 40mg/ml powder for oral suspension 

Meronem (meropenem trihydrate)
Great Britain

Meronem (meropenem trihydrate)IV 1g
Meronem (meropenem trihydrate) IV 500mg
Northern Ireland
Meronem (meropenem trihydrate)IV 1g
Meronem (meropenem trihydrate) IV 500mg

Ecalta (anidulafungin)
Great Britain

Ecalta (anidulafungin) Prescribing Information -  100mg powder for concentrate for solution for infusion
Northern Ireland
Ecalta (anidulafungin) Prescribing Information -  100mg powder for concentrate for solution for infusion

Diflucan (fluconazole)
Great Britain

Diflucan (fluconazole) Prescribing Information - 10mg/ml powder for oral suspension
Diflucan (fluconazole) Prescribing Information - 150mg capsules
Diflucan (fluconazole) Prescribing Information -  200mg hard capsules​​​​​​​
Diflucan (fluconazole) Prescribing Information -  40mg/ml powder for oral suspension
Diflucan (fluconazole) Prescribing Information -  50mg hard capsules

Northern Ireland

Diflucan (fluconazole) Prescribing Information - 10mg/ml powder for oral suspension
Diflucan (fluconazole) Prescribing Information - 150mg capsules
Diflucan (fluconazole) Prescribing Information -  200mg hard capsules​​​​​​​
Diflucan (fluconazole) Prescribing Information -  40mg/ml powder for oral suspension
Diflucan (fluconazole) Prescribing Information -  50mg hard capsules
​​​​​​​
Tazocin (piperacillin sodium, tazobactam sodium)
Great Britain

Tazocin (piperacillin sodium, tazobactam sodium) Prescribing Information -  2g/0.25g Powder for Solution for Infusion
Tazocin (piperacillin sodium, tazobactam sodium) Prescribing Information -  4g/0.5g powder for solution for infusion

​​​​​​​Northern Ireland
Tazocin (piperacillin sodium, tazobactam sodium) Prescribing Information -  2g/0.25g Powder for Solution for Infusion
Tazocin (piperacillin sodium, tazobactam sodium) Prescribing Information -  4g/0.5g powder for solution for infusion

Ciprofloxacin (ciprofloxacin lactate)
Great Britain

​​​​​​​​​​​​​​Ciprofloxacin (ciprofloxacin lactate) Prescribing information - 2mg/ml Solution for Infusion
Northern Ireland
​​​​​​​​​​​​​​Ciprofloxacin (ciprofloxacin lactate) Prescribing information - 2mg/ml Solution for Infusion

Amikacin (amikacin sulfate)
Great Britain

Amikacin (amikacin sulfate) Prescribing information - 500mg/2ml Solution for Injection
​​​​​​​Northern Ireland
Amikacin (amikacin sulfate) Prescribing information - 500mg/2ml Solution for Injection

​​​​​​

For UK Healthcare Professionals*

These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.

I confirm that I am a healthcare professional* resident in the United Kingdom.

If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.

*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.

PP-PFE-GBR-3863. November 2021

Yes

No

OK, We will need you to sign in before we can determine if you are aligned with a Pfizer promotional colleague.This is an interstitial message to prompt a HCP before they login.

If you have already registered with pfizerpro.co.uk and select ‘yes’, you will be directed to the sign-in page where you will be required to enter your username and password.

Would you like to register or sign in now?